Bottle of 120 MDI
Old MRP ₹498.88
MRP ₹467.7
₹374.16
₹3.9/MDI
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
Foracort 200 Synchrobreathe Inhaler is used to maintain long-term control of asthma and COPD by keeping the airways relaxed and free from inflammation. The inhaler delivers an anti-inflammatory corticosteroid together with a bronchodilator that widens the air passages. This combination helps reduce coughing, wheezing, chest tightness, and breathlessness while preventing future worsening of respiratory disease.
Foracort 200 Synchrobreathe Inhaler is used for long-term control of asthma and management of chronic obstructive pulmonary disease (COPD). It helps reduce airway inflammation, relax breathing muscles, and improve airflow to the lungs. Consistent use decreases wheezing, breathlessness, and flare-ups, supporting better lung function and daily activity tolerance.
Ensure you use Foracort 200 Synchrobreathe Inhaler correctly by following these steps:
Hold the inhaler upright and shake it well before each use.
Inhale the medicine slowly while pressing down on the canister to release one dose at a time.
Hold your breath for a few seconds after each inhalation to allow the medicine to reach deep into your lungs.
Wait for at least one minute before taking the next puff, if needed.
Foracort 200 Synchrobreathe Inhaler is administered by oral inhalation.
Common side effects of Foracort 200 Synchrobreathe Inhaler include palpitations, headache, tremors, throat irritation, cough, hoarseness, oral fungal infection, and chest infections.
Most side effects are temporary and generally harmless, which are resolved by discontinuing the use of Foracort 200 Synchrobreathe Inhaler. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor. Here are some general guidelines for managing common side effects:
Foracort 200 Synchrobreathe Inhaler contains two active ingredients:
If you are pregnant, caution is advised while using Foracort 200 Synchrobreathe Inhaler. It is best to consult your doctor before starting this medicine.
Budesonide, one of the active ingredients in Foracort 200 Synchrobreathe Inhaler, is found in breast milk. Therefore, caution is advised if you are breastfeeding.
There's no known interaction between Foracort 200 Synchrobreathe Inhaler and alcohol. However, it's always wise to discuss your drinking habits with your doctor.
Your liver health shouldn't affect your use of Foracort 200 Synchrobreathe Inhaler. Still, if you have a history of liver problems, mention it to your doctor.
Kidney health issues should not affect the use of this inhaler. But if you have any kidney-related health concerns, make sure to discuss them with your doctor.
Foracort 200 Synchrobreathe Inhaler has no known impact on your ability to operate machinery or drive vehicles.
If you're allergic to formoterol fumarate or budesonide, the two active ingredients in Foracort 200 Synchrobreathe Inhaler, do not use this medicine.
Foracort 200 Synchrobreathe Inhaler has not been established as safe for children under 6 years old. If you're considering it for a child, consult your doctor first.
Older patients can use Foracort 200 Synchrobreathe Inhaler under medical supervision. As they may be more susceptible to side effects or have other health conditions like liver and kidney issues, it's advisable to discuss any concerns with your doctor.
Foracort 200 Synchrobreathe Inhaler interacts with the following medicines:
Foracort 200 Synchrobreathe Inhaler interacts with certain foods:
The inhaler interacts with the following diseases:
The daily dose of Foracort 200 Synchrobreathe Inhaler should be administered as prescribed by your doctor. The dosage may vary based on individual factors like the severity of your condition and your response to the medicine. Always follow your doctor's instructions about the dosage and never exceed it without consulting them. For further details regarding the dosage, refer to the package insert.
In case you accidentally take more than your prescribed dose of Foracort 200 Synchrobreathe Inhaler, you might experience symptoms such as trembling hands, headaches, or a faster heartbeat. It's crucial that you inform your doctor if these symptoms persist or worsen.
If you happen to miss a dose of this medicine, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed one and continue with your regular schedule. Never increase your dosage without consulting your doctor.
| Available Dosage Types | Inhaler |
| Habit Forming | No |
| Ailment | Asthma, Chronic Obstructive Pulmonary Disease |
| Drug Category | Beta2-Agonist, Corticosteroid |
| Therapeutic Category | Bronchodilator, Anti-inflammatory |
It is used to manage long-term conditions like asthma and chronic obstructive pulmonary disease (COPD) in adults and children over 6 years old.
It contains budesonide, which reduces airway inflammation and formoterol fumarate, which relaxes airway muscles to improve breathing.
No, it's not meant for acute symptoms. Always have a fast-acting inhaler available for sudden breathlessness.
Common side effects can include palpitations, headache, tremors, throat irritation, coughing, and oral thrush.
You should avoid using it if you're hypersensitive to formoterol, budesonide, or any other ingredients in the inhaler.
Yes, use with caution if you have cardiovascular disorders, convulsive disorders, diabetes mellitus or are unusually responsive to sympathomimetic amines.
Keep it between 15-30°C; do not freeze or puncture the canister as its contents are under pressure.
Check out Editorial Policy
U.S. National Library of Medicine. (2022). Budesonide and Formoterol (Inhalation Route). MedlinePlus. Retrieved 1 April 2024, from https://medlineplus.gov/druginfo/meds/a699056.html
U.S. National Library of Medicine. (2022). Formoterol (Inhalation Route). MedlinePlus. Retrieved 1 April 2024, from https://medlineplus.gov/druginfo/meds/a623022.html
U.S. Food and Drug Administration. (1998). NDA 20-441/S-002: Approval Letter. AccessData. Retrieved 1 April 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20441s2.lbl.pdf
U.S. Food and Drug Administration. (2001). NDA 20-831/S-002: Approval Letter. AccessData. Retrieved 1 April 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20831s2lbl.pdf
Cates, C. J., & Karner, C. (2013). Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. The Cochrane database of systematic reviews, 2013(4), CD007313. https://doi.org/10.1002/14651858.CD007313.pub3
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
9032 users bought this instead
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.12.2
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
Composition
